GSK is voluntarily recalling three lots of children’s cough syrup that contain incorrect dosing cups, which could lead to an overdose.
The company is recalling Children's Robitussin Honey Cough and Chest Congestion DM (4 ounce) lots 02177 and 02178, which expire in January 2022, and Children's Dimetapp Cold and Cough (8 ounce) lot CL8292, which expires in September 2021. They were distributed nationwide between Feb. 5 and June 3, according to a notice from the Food and Drug Administration (FDA).
The Robitussin dosing cups are missing 5 milliliter (mL) and 10mL markings, and Dimetapp is missing the 10 mL marking, which could lead caregivers to provide the wrong amount to children.
Symptoms of overdose include impaired coordination; brain stimulation causing increase in energy, elevation in blood pressure, heart rate and respiration; severe dizziness or drowsiness; slow heart rate; fainting; psychotic behavior; restlessness; seizure; decreased respiration; nausea; vomiting; constipation; diarrhea; abdominal pain; visual and hearing hallucinations; and urinary retention, according to the FDA notice.
No adverse events have been reported. Anyone who experiences such a reaction should contact their health care provider and can report problems to the FDA’s MedWatch Adverse Event Reporting Program. Consumers with questions or problems also can call GSK at 800-762-4675.
Over-the-counter cough and cold medicines should not be given to very young children, and from ages 4-6 years, they should be used only if recommended by a child’s doctor. HealthyChildren.org has home remedy recommendations at https://bit.ly/3dsGhm9.
